No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Chemotherapy, Adjuvant
-
Female
-
Humans
-
Lymphatic Metastasis / pathology
-
Prognosis
-
Receptor, ErbB-2 / analysis*
-
Trastuzumab
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
ERBB2 protein, human
-
Receptor, ErbB-2
-
Trastuzumab